Thailand - Healthcare, Regulatory and Reimbursement Landscape: CountryFocus

Thailand - Healthcare, Regulatory and Reimbursement Landscape: CountryFocus

Summary

GlobalData, the industry analysis specialist, has released its latest report, “Thailand - Healthcare, Regulatory and Reimbursement Landscape: CountryFocus”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Thailand. It identifies the key trends in the healthcare market and provide insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Thailand. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Thailand pharmaceutical market is one of the growing markets in the South East Asian region. It was valued at $4.4B in 2012, which increased to $5.8B in 2017. It is forecast to reach $8.5B by 2024. The growing pharmaceutical market is attributed to the increasing non communicable diseases such as heart diseases, diabetes, stroke, and cancer; growth of aging population; universal health coverage leading to better access to healthcare services and expenditure on medicines; expansion of medical tourism industry and increasing number of foreign patients. In 2017, Thailand’s medical device market was worth $1.26B, which is estimated to reach $1.45B in 2020 with a CAGR of 4.87%.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Thailand, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Novartis, GSK, Sanofi, and Jack Chia)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Thailand
- An insightful review of the reimbursement and regulatory landscape, of which analysis include details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding the health-tech landscape of the country
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Thailand healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Thailand healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Thailand healthcare market